Open label trial of tamoxifen is scleroderma

Clinical and Experimental Rheumatology

Volumn 21, Issue 1, 2003, Pages 99-102

  Thomas Golbanov, Colleen K ^a   Wilke, William S ^a   Fessler, Barri J ^a   Hoffman, Gary S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

CREST; Scleroderma; Systemic sclerosis; Tamoxifen

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIESTROGEN; CALCIUM CHANNEL BLOCKING AGENT; CISAPRIDE; COLCHICINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; HYDROXYCHLOROQUINE; METHOTREXATE; PENICILLAMINE; PROTON PUMP INHIBITOR; TAMOXIFEN; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; LUNG EMBOLISM; MALE; MIGRAINE; MUSCLE WEAKNESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RELAPSE; SCLERODERMA; SYNDROME CREST; TREATMENT OUTCOME; TREMOR; VERTIGO;

AGED; CREST SYNDROME; ENDPOINT DETERMINATION; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; TAMOXIFEN; TREATMENT OUTCOME;

EID: 0037285587     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. WIGLEY FM, SULE SD: Novel therapy in the treatment of scleroderma. [erratum appears in Expert Opin Investig Drugs 2001; 10 (2): 407]. Expert Opin Investig Drugs 2001; 10: 31-48.
2. FRANCO LG, REFOJO DE BRUNO L, DE FOSSATI LM, DE FONSECA MLS, ROLDAN Y EJ: Tamoxifeno: Nueva propuesta terapeutica en esclerodermia y enfermedad de Raynaud. Estudio preliminar mediante registros distales de temperatura. Rev Argentina de Dermatologia 1988; 69: 169-76.
3. DA CONCEICAO MM, MARTINS AM, Da COSTA FERNANDES M: Tamoxifeno no tratamento da fibroesclerose multifocal. Arquivos Brasileiros de Medicina 1995; 69: 475-6.
4. CHAO AS, LAI CH, HSUEH S, CHEN CS, YANG YC, SOONG YK: Successful treatment of recurrent pelvic desmoid tumour with tamoxifen: case report. Human Reprod 2000; 15: 311-3.
5. LACKNER H, URBAN C, KERBL R, SCHWINGER W, BEHAM A: Non-cytotoxic drug therapy in children with unresectable desmoid tumors. Cancer 1997;80:334-40,.
6. LYNCH HT, FITZGIBBONS R JR: Surgery, desmoid tumors, and familial adenomatous polyposis: Case report and literature review. Amer J Gastroenterol 1996; 91: 2598-601.
7. BROOKS MD, EBBS SR, COLLETTA AA, BAUM M: Desmoid tumours treated with triphenylethylenes. Eur J Cancer 1992; 28A: 1014-8.
8. PROCTER H, SINGH L, BAUM M, BRINKLEY D: Response of multicentric desmoid tumours to tamoxifen. Br J Surg 1987; 74: 401.
9. DEDEOGLU F, ROSE CD, ATHREYA BH, CONARD K, GRISSOM L, MAGNUSSON M: Successful treatment of retroperitoneal fibrosis with tamoxifen in a child. J Rheumatol 2001; 28: 1693-5,
10. FRANKART L, LORGE F, DONCKIER J: Tamoxifen for retroperitoneal fibrosis. Postgrad Med J 1997; 73: 653-4.
11. BOUROUMA R, CHEVET D, MICHEL F, CERCUEIL JP, ARNOULD L, RIFLE G: Treatment of idiopathic retroperitoneal fibrosis with tamoxifen. Nephrol, Dial, Transplant 1997; 12: 2407-10.
12. TONIETTO G, AGRESTA F, DELLA LIBERA D, BITTESINI L: Treatment of idiopathic retroperitoneal fibrosis by tamoxifen. Eur J Surg 1997; 163: 231-5.
13. OWENS LV, CANCE WG, HUTH JF: Retroperitoneal fibrosis treated with tamoxifen. Amer Surg 1995; 61: 842-4.
14. TIMMONS MJ: Fibromatosis, desmoids, fibroblasts, and tamoxifen. Brit J Plastic Surg 1994; 47: 378-80.
15. BENSON JR, BAUM M: Tamoxifen for retroperitoneal fibrosis. [letter; comment]. Lancet 1993; 341: 836.
16. LEKAKIS J, MAVRIKAKIS M, EMMANUEL M, PRASSOPOULOS V, PAPAMICHAEL C, MOULOPOULOS S: Acute estrogen administration can reverse cold-induced coronary Raynaud's phenomenon in systemic sclerosis. Clin Exp Rheumatol 1996; 14: 421-4.
17. LEKAKIS J, MAVRIKAKIS M, PAPAMICHAEL, C, PAPAZOGLOU S, ECONOMOU O, MOULOPOULOS S: Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon. Am Heart J 1998; 136: 905-12.
18. LEKAKIS J, PAPAMICHAEL C, MAVRIKAKIS M, VOUTSAS A, STAMATELOPOULOS S: Effect of long term estrogen therapy on brachial arterial endothelium-dependent vasodilation in women with Raynaud's phenomenon secondary to systemic sclerosis. Am J Cardiol 1998; 82: 1555-7.
19. WHITE B, BAUER EA, GOLDSMITH LA, HOCHBERG MC, KATZ LM, PAULUS HE: Guidelines for clinical trials in systemic sclerosis (Scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Arthritis Rheum 1995; 38: 351-60.
20. BRATHERTON DG, BROWN CH, BUCHANAN R et al.: A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd. Brit J Cancer 1984; 50: 199-205.